New Aspects of Clinical and Cellular Pharmacodynamics of Methotrexate with Special Emphasis on Its Role in the Treatment of Acute Lymphoblastic Leukemia in Children
- 1 December 1987
- journal article
- review article
- Published by Wiley in Acta Paediatrica
- Vol. 76 (s341) , 1-31
- https://doi.org/10.1111/j.1651-2227.1987.tb10587.x
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Inhibition of cell proliferation by putative metabolites and non-degradable analogs of methotrexate-Y-dimyristoylphosphatidylethanolamineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute ChromosomesNew England Journal of Medicine, 1983
- Anion exchange mechanism for transport of methotrexate in L1210 cellsBiochemical and Biophysical Research Communications, 1981
- Change in Transfer Rate of Methotrexate from Spinal Fluid to Plasma during Intrathecal Therapy in Children and AdultsClinical Pharmacokinetics, 1980
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Analogs of Pteroylglutamic Acid. III. 4-Amino DerivativesJournal of the American Chemical Society, 1949
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948
- ANTAGONIST FOR PTEROYLGLUTAMIC ACIDJournal of the American Chemical Society, 1947